Compare Biocon Ltd with Piramal Healthcare - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs PIRAMAL ENTERPRISES - Comparison Results

BIOCON      Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

PIRAMAL ENTERPRISES 
   Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON PIRAMAL ENTERPRISES BIOCON /
PIRAMAL ENTERPRISES
 
P/E (TTM) x 30.2 17.0 177.6% View Chart
P/BV x 3.9 1.2 333.2% View Chart
Dividend Yield % 0.3 2.0 12.7%  

Financials

 BIOCON    PIRAMAL ENTERPRISES
EQUITY SHARE DATA
    BIOCON
Mar-19
PIRAMAL ENTERPRISES
Mar-19
BIOCON /
PIRAMAL ENTERPRISES
5-Yr Chart
Click to enlarge
High Rs7073,303 21.4%   
Low Rs5541,797 30.8%   
Sales per share (Unadj.) Rs91.9716.5 12.8%  
Earnings per share (Unadj.) Rs16.779.7 21.0%  
Cash flow per share (Unadj.) Rs24.2107.9 22.4%  
Dividends per share (Unadj.) Rs1.0028.00 3.6%  
Dividend yield (eoy) %0.21.1 14.4%  
Book value per share (Unadj.) Rs101.61,477.5 6.9%  
Shares outstanding (eoy) m600.00184.45 325.3%   
Bonus/Rights/Conversions -IS-  
Price / Sales ratio x6.93.6 192.8%   
Avg P/E ratio x37.732.0 118.0%  
P/CF ratio (eoy) x26.123.6 110.4%  
Price / Book Value ratio x6.21.7 359.5%  
Dividend payout %6.035.1 17.0%   
Avg Mkt Cap Rs m378,330470,292 80.4%   
No. of employees `0006.17.8 78.4%   
Total wages/salary Rs m11,65322,504 51.8%   
Avg. sales/employee Rs Th8,994.316,899.4 53.2%   
Avg. wages/employee Rs Th1,900.72,877.7 66.0%   
Avg. net profit/employee Rs Th1,635.31,879.9 87.0%   
INCOME DATA
Net Sales Rs m55,144132,153 41.7%  
Other income Rs m1,4443,128 46.2%   
Total revenues Rs m56,588135,281 41.8%   
Gross profit Rs m15,88366,290 24.0%  
Depreciation Rs m4,4785,202 86.1%   
Interest Rs m70944,097 1.6%   
Profit before tax Rs m12,14020,119 60.3%   
Minority Interest Rs m93,194 0.3%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,1238,611 24.7%   
Profit after tax Rs m10,02614,701 68.2%  
Gross profit margin %28.850.2 57.4%  
Effective tax rate %17.542.8 40.9%   
Net profit margin %18.211.1 163.4%  
BALANCE SHEET DATA
Current assets Rs m48,228122,742 39.3%   
Current liabilities Rs m30,376310,810 9.8%   
Net working cap to sales %32.4-142.3 -22.7%  
Current ratio x1.60.4 402.0%  
Inventory Days Days6823 296.0%  
Debtors Days Days8639 220.1%  
Net fixed assets Rs m64,130116,904 54.9%   
Share capital Rs m3,000369 813.2%   
"Free" reserves Rs m57,980272,161 21.3%   
Net worth Rs m60,980272,530 22.4%   
Long term debt Rs m15,766270,196 5.8%   
Total assets Rs m121,924856,261 14.2%  
Interest coverage x18.11.5 1,244.5%   
Debt to equity ratio x0.31.0 26.1%  
Sales to assets ratio x0.50.2 293.0%   
Return on assets %8.86.9 128.2%  
Return on equity %16.45.4 304.8%  
Return on capital %16.812.4 134.9%  
Exports to sales %28.10-   
Imports to sales %18.90-   
Exports (fob) Rs m15,506NA-   
Imports (cif) Rs m10,399NA-   
Fx inflow Rs m15,50615,200 102.0%   
Fx outflow Rs m10,3994,889 212.7%   
Net fx Rs m5,10710,312 49.5%   
CASH FLOW
From Operations Rs m11,546-115,975 -10.0%  
From Investments Rs m-7,138-8,265 86.4%  
From Financial Activity Rs m-2,417107,525 -2.2%  
Net Cashflow Rs m2,103-16,650 -12.6%  

Share Holding

Indian Promoters % 40.4 52.9 76.4%  
Foreign collaborators % 20.6 0.0 -  
Indian inst/Mut Fund % 8.4 4.0 210.0%  
FIIs % 10.7 26.6 40.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.9 16.5 120.6%  
Shareholders   109,995 93,274 117.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   TTK HEALTHCARE  ALEMBIC LTD  DR. REDDYS LAB  ELDER PHARMA  UNICHEM LAB  

Compare BIOCON With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 178 Points Higher; Telecom and Power Stocks Witness Buying(Closing)

Indian share markets witnessed buying interest throughout the day today and ended on a positive note.

Related Views on News

PIRAMAL ENTERPRISES Announces Quarterly Results (3QFY20); Net Profit Up 11.7% (Quarterly Result Update)

Feb 5, 2020 | Updated on Feb 5, 2020

For the quarter ended December 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 6 bn (up 11.7% YoY). Sales on the other hand came in at Rs 38 bn (up 9.1% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

BIOCON Announces Quarterly Results (3QFY20); Net Profit Up 1.2% (Quarterly Result Update)

Jan 24, 2020 | Updated on Jan 24, 2020

For the quarter ended December 2019, BIOCON has posted a net profit of Rs 2 bn (up 1.2% YoY). Sales on the other hand came in at Rs 17 bn (up 13.5% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (2QFY20); Net Profit Down 30.5% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, BIOCON has posted a net profit of Rs 3 bn (down 30.5% YoY). Sales on the other hand came in at Rs 16 bn (up 19.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (2QFY20); Net Profit Up 16.5% (Quarterly Result Update)

Oct 25, 2019 | Updated on Oct 25, 2019

For the quarter ended September 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 6 bn (up 16.5% YoY). Sales on the other hand came in at Rs 36 bn (up 14.6% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY20); Net Profit Up 390.0% (Quarterly Result Update)

Aug 1, 2019 | Updated on Aug 1, 2019

For the quarter ended June 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 4 bn (up 390.0% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

More Views on News

Most Popular

Be Prepared to Profit from the Coming Crash in Oil Prices(Fast Profits Daily)

Jun 25, 2020

The stability in crude oil prices will not last much longer. Be ready to make fast profits when the time comes to short crude.

Tata Motors Tripled in 18 Months but You Can Do Even Better. Here's How...(Profit Hunter)

Jun 24, 2020

Rahul is ready for a repeat of his famous 2008 Tata Motors call.

The Triple Digit Return Opportunity in this Market

Jun 24, 2020

Rahul Shah on stocks with potentially triple digit returns.

This Ratio Says Smallcaps Are Your Best Bet to Ride the Post Covid Market Rebound(Profit Hunter)

Jun 23, 2020

Here's why I believe that post Covid rebound in smallcaps will be much sharper than largecaps.

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON SHARE PRICE


Jul 3, 2020 (Close)

TRACK BIOCON

BIOCON - AUROBINDO PHARMA COMPARISON

COMPARE BIOCON WITH

MARKET STATS